FDA Approved: DEFERASIROX — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approves a generic version of deferasirox (Cipla) under an original ANDA application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Transfusional Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)